Skip to content
peptide

DSIP (Delta Sleep-Inducing Peptide)

moderateResearch Use OnlyInjectionIntranasal

Brain peptide that promotes deep delta-wave sleep. Normalizes disrupted sleep patterns and reduces stress without next-day grogginess.


Key facts
Classification
Delta Sleep-Inducing Peptide is a nonapeptide that increases delta wave (Stage III/IV) activity without suppressing REM sleep.
Primary benefits
Sleep (7/10) · Mood & Anxiety (5/10) · Longevity (3/10)
Administration
Injection, Intranasal
Doses studied
100-200 mcg subq or nasal spray about 30 minutes before bed. Use 5 days on, 2 days off.
Evidence strength
Moderate — 20 peer-reviewed studies
Stacks well with
Epithalon, Selank, MK-677, Pinealon
Legal status
Research Use Only · not prescribable in US
Quick stats
Type
Peptide
Administration
Injection, Intranasal
Studies referenced
20
Stacks with
4 peptides
Regulatory
Research Use Only
Scientific overview

Delta Sleep-Inducing Peptide is a nonapeptide that increases delta wave (Stage III/IV) activity without suppressing REM sleep. Modulates serotonergic and GABAergic systems with stress-protective effects via HPA axis normalization. Exhibits opiate antagonist properties.

Goal coverage · DSIP (Delta Sleep-Inducing Peptide)
😴 Sleep7/10
😌 Mood & Anxiety5/10
Longevity3/10
FIG.1  Modeled goal coverage from reviewed studies. Score out of 10.
Medical oversight recommendedNot safe during pregnancy· 3 contraindications
From our network:Cornerstone Peptide